MCID: RTN001
MIFTS: 46

Retinal Vasculitis

Categories: Cardiovascular diseases, Eye diseases

Aliases & Classifications for Retinal Vasculitis

MalaCards integrated aliases for Retinal Vasculitis:

Name: Retinal Vasculitis 12 54 43 15 17 71

Classifications:



External Ids:

Disease Ontology 12 DOID:11563
ICD9CM 34 362.18
MeSH 43 D031300
SNOMED-CT 67 77628002
ICD10 32 H35.06
UMLS 71 C0152026

Summaries for Retinal Vasculitis

Disease Ontology : 12 A vasculitis that is characterized by inflammation of the vascular branches of the retinal artery and has symptom painless decrease of visual acuity, visual floaters, dark spot in vision, decreased ability to distinguish colors, and distortion of images such as linear images.

MalaCards based summary : Retinal Vasculitis is related to eales disease and vasculitis, and has symptoms including painless decrease of visual acuity and eye manifestations. An important gene associated with Retinal Vasculitis is SAG (S-Antigen Visual Arrestin), and among its related pathways/superpathways are PEDF Induced Signaling and Akt Signaling. The drugs Methylprednisolone and Methylprednisolone hemisuccinate have been mentioned in the context of this disorder. Affiliated tissues include eye, t cells and skin, and related phenotypes are Synthetic lethal with MLN4924 (a NAE inhibitor) and Synthetic lethal with MLN4924 (a NAE inhibitor)

Wikipedia : 74 Retinal vasculitis is inflammation of the vascular branches of the retinal artery, caused either by... more...

Related Diseases for Retinal Vasculitis

Diseases related to Retinal Vasculitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 385)
# Related Disease Score Top Affiliating Genes
1 eales disease 32.4 SOD1 SAG RBP3 NOS2
2 vasculitis 30.9 TNFRSF1B CD40LG CCL2 APOH
3 neuritis 30.8 CX3CR1 CCL4 CCL2
4 retinal artery occlusion 30.5 CCL2 APOH ACE
5 neuroretinitis 30.3 SAG MRAP CD40LG ACE
6 uveitis 30.1 TNFRSF1B SAG RBP3 CCL4 CCL2
7 posterior uveitis 29.9 SAG RBP3 MRAP CCR6
8 retinal vein occlusion 29.9 CD40LG CCL2 APOH ACE
9 posterior scleritis 29.7 MRAP ACE
10 cat-scratch disease 29.7 CD40LG ACE
11 human immunodeficiency virus type 1 29.7 TLR3 CX3CR1 CCL4 CCL2
12 papilledema 29.6 CD40LG APOH ACE
13 optic nerve disease 29.5 IFNB1 CD40LG CCR6 ACE
14 macular retinal edema 29.5 TNFRSF1B MRAP IFNB1 CCL2 ACE
15 scleritis 29.4 TNFRSF1B MRAP CCR6 CCL2
16 glomerulonephritis 29.4 NOS2 CD40LG CCL2 ACE
17 pyoderma 29.3 TNFRSF1B CCR6 APOH
18 chickenpox 29.3 TNFRSF1B TLR3 CD40LG CCR6
19 microvascular complications of diabetes 5 29.3 SOD1 NOS2 ACE
20 myelitis 29.3 IFNB1 CD40LG CCR6 APOH
21 enthesopathy 29.2 TNFRSF1B MRAP CCR6
22 syphilis 29.2 MRAP CD40LG CCR6 APOH ACE
23 hypopyon 29.2 TNFRSF1B RBP3 MRAP
24 granulomatosis with polyangiitis 29.1 TNFRSF1B CD40LG CCR6
25 mononeuritis multiplex 29.1 TNFRSF1B CD40LG
26 choroiditis 29.1 SAG RBP3 MRAP CD40LG ACE
27 encephalitis 29.0 TLR3 NOS2 CD40LG CCL4 CCL2
28 rubella 29.0 TNFRSF1B TLR3 IFNB1 CD40LG
29 vascular disease 29.0 SOD1 NOS2 CD40LG CCL2 APOH ACE
30 rheumatic disease 29.0 TNFRSF1B CD40LG CCR6 APOH
31 lung disease 28.9 SOD1 CD40LG CCL2 ACE
32 immune deficiency disease 28.9 CX3CR1 CD40LG CCR6 CCL4 CCL2
33 mycobacterium tuberculosis 1 28.9 TNFRSF1B IFNB1 CCR6 CCL4
34 myocarditis 28.8 TLR3 NOS2 CD40LG CCL2 ACE
35 temporal arteritis 28.6 TNFRSF1B CD40LG CCR6 CCL2 APOH
36 iridocyclitis 28.5 TNFRSF1B RBP3 MRAP CD40LG ACE
37 exanthem 28.5 TNFRSF1B CD40LG CCR6 ACE
38 spondyloarthropathy 1 28.5 TNFRSF1B MRAP CD40LG CCR6
39 acquired immunodeficiency syndrome 28.5 TNFRSF1B NOS2 CD40LG CCR6
40 optic papillitis 28.3 TNFRSF1B RBP3 MRAP CD40LG ACE
41 chorioretinitis 28.1 TNFRSF1B SAG RBP3 MRAP CD40LG ACE
42 sarcoidosis 1 28.1 TNFRSF1B MRAP CD40LG CCR6 CCL4 CCL2
43 iritis 27.9 TNFRSF1B MRAP CD40LG CCR6 ACE
44 rheumatoid arthritis 27.8 TNFRSF1B NOS2 CX3CR1 CD40LG CCR6 CCL4
45 panuveitis 27.8 TNFRSF1B SAG RBP3 MRAP CD40LG CCR6
46 connective tissue disease 27.8 TNFRSF1B MRAP CD40LG CCR6 CCL2 APOH
47 autoimmune disease 27.8 TNFRSF1B SAG RBP3 IFNB1 CD40LG CCR6
48 systemic lupus erythematosus 27.5 TNFRSF1B TLR3 IFNB1 CX3CR1 CD40LG CCR6
49 eye disease 27.3 SAG RBP3 MRAP CX3CR1 CD40LG CCR6
50 multiple sclerosis 27.3 TNFRSF1B TLR3 SAG NOS2 IFNB1 CX3CR1

Graphical network of the top 20 diseases related to Retinal Vasculitis:



Diseases related to Retinal Vasculitis

Symptoms & Phenotypes for Retinal Vasculitis

Symptoms:

12
  • painless decrease of visual acuity

UMLS symptoms related to Retinal Vasculitis:


eye manifestations

GenomeRNAi Phenotypes related to Retinal Vasculitis according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-1 9.72 ACE APOH CD40LG NOS2 SOD1 TNFRSF1B
2 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-2 9.72 ACE APOH CD40LG NOS2 SOD1 TNFRSF1B

MGI Mouse Phenotypes related to Retinal Vasculitis:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.07 ACE APOH ARR3 CCR6 CD40LG CX3CR1
2 cardiovascular system MP:0005385 9.97 ACE ARR3 CCR6 CD40LG CX3CR1 NOS2
3 immune system MP:0005387 9.85 ACE CCL2 CCR6 CD40LG CX3CR1 IFNB1
4 neoplasm MP:0002006 9.43 ACE IFNB1 NOS2 SOD1 TLR3 TNFRSF1B
5 nervous system MP:0003631 9.32 CCR6 CD40LG CX3CR1 IFNB1 NOS2 RBP3

Drugs & Therapeutics for Retinal Vasculitis

Drugs for Retinal Vasculitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 62)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
2
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
3
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
4 Prednisolone acetate Approved, Vet_approved Phase 4 52-21-1
5
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
6
Ranibizumab Approved Phase 4 347396-82-1 459903
7
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7
8 Methylprednisolone Acetate Phase 4
9 Antiemetics Phase 4
10 Gastrointestinal Agents Phase 4
11 Neuroprotective Agents Phase 4
12 Anti-Inflammatory Agents Phase 4
13 Autonomic Agents Phase 4
14 Antineoplastic Agents, Hormonal Phase 4
15 Protective Agents Phase 4
16 glucocorticoids Phase 4
17 Autoantibodies Phase 4
18 Antibodies Phase 4
19 Immunoglobulins Phase 4
20 Angiogenesis Inhibitors Phase 4
21 Hormone Antagonists Phase 4
22 Melanocyte-Stimulating Hormones Phase 4
23 Adrenocorticotropic Hormone Phase 4
24 beta-endorphin Phase 4
25 Hormones Phase 4
26
Miconazole Approved, Investigational, Vet_approved Phase 3 22916-47-8 4189
27 Anti-Infective Agents Phase 3
28 Immunologic Factors Phase 3
29 Dermatologic Agents Phase 3
30 Antiviral Agents Phase 3
31 Cyclosporins Phase 3
32 Antifungal Agents Phase 3
33 Antirheumatic Agents Phase 3
34 Interferon-alpha Phase 3
35 Immunosuppressive Agents Phase 3
36 Interferon alpha-2 Phase 3
37 interferons Phase 3
38 Calcineurin Inhibitors Phase 3
39
tannic acid Approved Phase 2 1401-55-4
40
Benzocaine Approved, Investigational Phase 2 1994-09-7, 94-09-7 2337
41
Methotrexate Approved Phase 2 1959-05-2, 59-05-2 126941
42
Cyclophosphamide Approved, Investigational Phase 2 50-18-0, 6055-19-2 2907
43
Azathioprine Approved Phase 2 446-86-6 2265
44
rituximab Approved Phase 2 174722-31-7 10201696
45 Antibodies, Monoclonal Phase 2
46 Analgesics Phase 2
47 Analgesics, Non-Narcotic Phase 2
48 Antineoplastic Agents, Immunological Phase 2
49 Interleukin-2 Phase 2
50
Altretamine Approved Phase 1 645-05-6 2123

Interventional clinical trials:

(show all 16)
# Name Status NCT ID Phase Drugs
1 The Efficacy of Intravenous Pulses of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease, a Double Blind Pilot Study Unknown status NCT01306955 Phase 4 methylorednisolone
2 Correlation of Functional and Structural Outcomes With Serum Antibody Profiles in Patients With Neovascular Age-related Macular Degeneration Treated With Ranibizumab and Healthy Subjects: A Prospective, Controlled Monocenter Trial Completed NCT02843490 Phase 4 Ranibizumab
3 Open-label, Single-center, Prospective Study on the Efficacy and Safety of Repository Corticotropin Injection (H.P. ACTHAR GEL) in the Treatment of Adults With Non-infectious Retinal Vasculitis Recruiting NCT03066869 Phase 4 H.P. ACTHAR GEL
4 Phase III Study of Recombinant Human Interferon-alpha2a Versus Cyclosporin A for the Treatment of Ocular Behcet`s Disease - a National,Randomised, Single-masked Controlled Trial (INCYTOB) Completed NCT00167583 Phase 3 Cyclosporin A;Interferon-alpha2a
5 The Use of a VEGF Inhibitor (Lucentis) in Refractory Macular Edema Due to Eales' Disease Completed NCT00384449 Phase 2, Phase 3 Ranibizumab
6 An Open-label Proof-of-concept Study With a Double-masked, Dose-ranging Component to Assess the Effects of AIN457 in Patients With Noninfectious Uveitis Completed NCT00685399 Phase 2 AIN457;AIN 457;AIN457
7 Effect of Rituximab in the Treatment of Resistant Ocular Inflammatory Lesions of Behcet's Disease (Pilot Study) Completed NCT00664599 Phase 2 Rituximab;Cytotoxic Combination
8 A Study to Investigate the Safety and Efficacy of HAT to Treat the Ocular Complications Related to Behcet's Disease Completed NCT00001865 Phase 2 Daclizumab
9 Treatment of the Bilateral Severe Uveitis by IVT of Regulator T-cells: Study of Tolerance of Dose Suspended NCT02494492 Phase 1, Phase 2
10 Phase 1 Study of Bone Marrow - Derived Stem Cell in the Treatment of Ocular Lesions of Behcet's Disease Terminated NCT00550498 Phase 1
11 Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease Unknown status NCT00931957 Etanercept, Methotrexate, Prednisolone
12 Identification of Biological Markers in Retinal Vasculitis Completed NCT00050492
13 Ocular and Immuno-Genetic Manifestations of Sarcoidosis Completed NCT00379275
14 Analysing Tear Protein, Conjunctival Cells, and Imaging Eyes in Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus Completed NCT02217137
15 Evaluation of Macular Vascular Changes in Behcet's Disease Using Optical Coherence Tomography Angiography Recruiting NCT03264391
16 Evaluation of the Utility of OCT Angiography in Assessing Vascular Perfusion in Retinal Vasculitis Active, not recruiting NCT01998464

Search NIH Clinical Center for Retinal Vasculitis

Cochrane evidence based reviews: retinal vasculitis

Genetic Tests for Retinal Vasculitis

Anatomical Context for Retinal Vasculitis

MalaCards organs/tissues related to Retinal Vasculitis:

40
Eye, T Cells, Skin, Lung, Bone, Retina, Testes

Publications for Retinal Vasculitis

Articles related to Retinal Vasculitis:

(show top 50) (show all 1170)
# Title Authors PMID Year
1
Primate model of uveoretinitis and vasculitis/experimental autoimmune uveoretinitis induced in cynomolgus monkeys by retinal s antigen. 54 61
18421236 2008
2
Anticardiolipin antibodies in isolated retinal vasculitis. 54 61
8250085 1993
3
Markers of vascular injury in Behçet's disease associated with retinal vasculitis. 54 61
1476395 1992
4
Antibody affinity to retinal S-antigen in patients with retinal vasculitis. 54 61
1598962 1992
5
Anticardiolipin antibodies in uveitis. 54 61
1424747 1992
6
Rapid and progressive decline despite early intervention in a case of bilateral hemorrhagic occlusive retinal vasculitis. 61
31993532 2020
7
Automated measurement of leakage on wide-field angiography in the assessment of retinal vasculitis. 61
32009203 2020
8
The Detection of Occult Retinal Vasculitis on Fluorescein Angiography in Pediatric Uveitis. 61
31708487 2020
9
Retinal vascular inflammatory and occlusive changes in infectious and non-infectious uveitis. 61
32016664 2020
10
A Long-Term Follow-up of Retinal Vasculitis - Do They Develop Systemic Disease? 61
31906773 2020
11
UNILATERAL OPTIC NEURITIS AND CENTRAL RETINAL VASCULITIS DUE TO OCULAR SYPHILIS. 61
28816862 2020
12
Prognostic factors for TB-associated uveitis in the Asia-Pacific Region: results of a modified Delphi survey. 61
31896799 2020
13
Ocular Autoimmune Systemic Inflammatory Infectious Study (OASIS) - Report 2: Pattern of Uveitis Investigations in Singapore. 61
30335550 2020
14
Tuberculosis: A Cunning Disease Presenting with Endopericarditis-Associated Bilateral Uveitis 61
31893593 2019
15
Severe retinal vasculitis as a manifestation of poststreptococcal syndrome in a child. 61
31490618 2019
16
Resurgence of ocular syphilis in British Columbia between 2013-2016: a retrospective chart review. 61
31889521 2019
17
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases. 61
31237427 2019
18
Novel findings in enhanced S-cone syndrome: a case with macular retinal neovascularization and severe retinal vasculitis. 61
31292819 2019
19
Presumed atypical peripapillary Vogt-Koyanagi-Harada disease. 61
31517139 2019
20
Lessons of the month 2: A case of Behçet's disease: 70% have ophthalmic involvement. 61
31732597 2019
21
Clinical and Morphological Characteristics of Anti-Programmed Death Ligand 1-Associated Retinopathy: Expanding the Spectrum of Acute Macular Neuroretinopathy. 61
31926948 2019
22
Characteristics of Behcet's Disease in the American Southwest. 61
30952423 2019
23
Optical coherence tomography angiography findings in Behcet patients. 61
30710254 2019
24
High-Resolution Imaging of Retinal Vasculitis by Flood Illumination Adaptive Optics Ophthalmoscopy: A Follow-up Study. 61
31573376 2019
25
Miliary Retinal Lesions in Ocular Syphilis: Imaging Characteristics and Outcomes. 61
31580177 2019
26
Lesson of the month 2: A case of Behçet's disease: 70% have ophthalmic involvement. 61
31641065 2019
27
Multimodal Imaging of Parry Romberg Syndrome-associated Panuveitis: A Case Report and Review of Literature. 61
31577463 2019
28
Inferior Corneal Haze and Inflammatory Endotheliopathy Related to Pars Planitis. 61
31573365 2019
29
The fluorescein angiographic photodiagnosis of idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome: Outcome of combined therapy. 61
31260747 2019
30
Atypical Bilateral Hemorrhagic Occlusive Retinal Vasculitis Associated With Intraocular Vancomycin: Severe Vascular Obstruction and Delayed Onset of Retinal Hemorrhage. 61
31397745 2019
31
Evaluation of vascular changes in intermediate uveitis and retinal vasculitis using swept-source wide-field optical coherence tomography angiography. 61
30538102 2019
32
Low-grade "benign" birdshot retinochoroiditis: prevalence and characteristics. 61
30474776 2019
33
Clinical and Demographic Features of Pediatric-Onset Behçet's Disease and Evaluation of Optical Coherence Tomography Findings. 61
31560571 2019
34
Swept-source optical coherence tomography angiography reveals vascular changes in intermediate uveitis. 61
30729711 2019
35
THE COLLABORATIVE OCULAR TUBERCULOSIS STUDY (COTS)-1: A Multinational Review of 251 Patients With Tubercular Retinal Vasculitis. 61
29697588 2019
36
Confusional syndrome and retinal vasculitis. 61
31405588 2019
37
Successful Clinical Outcome of Vancomycin-induced Hemorrhagic Occlusive Retinal Vasculitis. 61
31418634 2019
38
Postoperative Cataract Endophthalmitis Masquerading as Hemorrhagic Occlusive Retinal Vasculitis (HORV): A Case Report. 61
31414916 2019
39
A case of Kawasaki disease complicated with retinal vasculitis. 61
31435981 2019
40
Human Adenovirus: An Unusual Causative Agent for Acute Retinal Necrosis Presented with Central Retinal Vascular Occlusion. 61
31411554 2019
41
Distance-Thresholded Intercapillary Area Analysis Versus Vessel-Based Approaches to Quantify Retinal Ischemia in OCTA. 61
31440425 2019
42
Retinal Vasculitis Associated with Ipilimumab. 61
31314622 2019
43
Association of Nonuveitic Retinal Vasculitis and Tractional Retinoschisis With Cystoid Macular Edema With Fabry Disease. 61
31268502 2019
44
Retinal vasculitis in primary Sjögren's syndrome. 61
30561743 2019
45
A new perspective for analyzing clinical characteristics of idiopathic retinal vasculitis, aneurysms, and neuroretinitis syndrome. 61
29934930 2019
46
Experience of using adalimumab in treating sight-threatening paediatric or adolescent Behcet's disease-related uveitis. 61
31367810 2019
47
Geographical variations in ocular and extra-ocular manifestations in Behçet's disease. 61
31329543 2019
48
Toxicities of and inflammatory responses to moxifloxacin, cefuroxime, and vancomycin on retinal vascular cells. 61
31278356 2019
49
Lyme-associated uveitis: Clinical spectrum and review of literature. 61
31238716 2019
50
[Eye and Behçet's disease]. 61
31164292 2019

Variations for Retinal Vasculitis

Expression for Retinal Vasculitis

Search GEO for disease gene expression data for Retinal Vasculitis.

Pathways for Retinal Vasculitis

Pathways related to Retinal Vasculitis according to GeneCards Suite gene sharing:

(show all 12)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.35 TNFRSF1B NOS2 IFNB1 CX3CR1 CD40LG CCR6
2
Show member pathways
13.06 TNFRSF1B TLR3 CX3CR1 CD40LG CCR6 CCL4
3
Show member pathways
12.67 TLR3 NOS2 IFNB1 CCL4 CCL2 ACE
4
Show member pathways
12.63 TNFRSF1B TLR3 IFNB1 CCL4 CCL2
5 12.29 TNFRSF1B TLR3 CD40LG CCL2
6 11.73 TNFRSF1B NOS2 CCL2
7
Show member pathways
11.69 TNFRSF1B CX3CR1 CCR6 CCL4 CCL2
8 11.68 TNFRSF1B IFNB1 CCL2
9 11.66 SAG RBP3 ARR3
10 11.35 NOS2 CCL4 CCL2
11 11.02 TNFRSF1B CCL4 CCL2
12 10.43 CX3CR1 CD40LG CCL2 ACE

GO Terms for Retinal Vasculitis

Cellular components related to Retinal Vasculitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.61 TNFRSF1B SOD1 RBP3 IFNB1 CD40LG CCL4
2 cell surface GO:0009986 9.55 TLR3 CX3CR1 CD40LG CCR6 APOH
3 extracellular space GO:0005615 9.28 TLR3 SOD1 RBP3 IFNB1 CD40LG CCL4

Biological processes related to Retinal Vasculitis according to GeneCards Suite gene sharing:

(show all 15)
# Name GO ID Score Top Affiliating Genes
1 signal transduction GO:0007165 10.08 TLR3 SAG CX3CR1 CD40LG CCR6 CCL4
2 inflammatory response GO:0006954 9.77 TNFRSF1B TLR3 CD40LG CCL4 CCL2
3 cell surface receptor signaling pathway GO:0007166 9.76 TNFRSF1B SAG IFNB1 CCL2
4 response to virus GO:0009615 9.71 TLR3 IFNB1 CCL4
5 cellular response to lipopolysaccharide GO:0071222 9.71 TNFRSF1B NOS2 CX3CR1 CCL2
6 cell chemotaxis GO:0060326 9.67 CX3CR1 CCR6 CCL2
7 cytokine-mediated signaling pathway GO:0019221 9.65 TNFRSF1B NOS2 IFNB1 CCL4 CCL2
8 immune response GO:0006955 9.63 TNFRSF1B CX3CR1 CD40LG CCR6 CCL4 CCL2
9 chemotaxis GO:0006935 9.62 CX3CR1 CCR6 CCL4 CCL2
10 humoral immune response GO:0006959 9.61 IFNB1 CCR6 CCL2
11 cellular response to exogenous dsRNA GO:0071360 9.55 TLR3 IFNB1
12 heart contraction GO:0060047 9.52 SOD1 ACE
13 G protein-coupled receptor internalization GO:0002031 9.51 SAG ARR3
14 cellular response to interferon-gamma GO:0071346 9.26 TLR3 NOS2 CCL4 CCL2
15 chemokine-mediated signaling pathway GO:0070098 8.92 CX3CR1 CCR6 CCL4 CCL2

Molecular functions related to Retinal Vasculitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.26 IFNB1 CD40LG CCL4 CCL2
2 opsin binding GO:0002046 8.62 SAG ARR3

Sources for Retinal Vasculitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....